MoonLake Immunotherapeutics AG (MoonLake; Nasdaq: MLTX), today announced that it has signed a Master Development Services Agreement with Vetter Pharma International GmbH (Vetter), a leading global contract development and manufacturing organization for fill and finish services, ranging from development support, including clinical manufacturing, through to commercial supply.
July 26, 2022
· 6 min read